Is it worth it? Determining the health benefits of sleeve gastrectomy in patients with a body mass index <35 kg/m2
| Autor: | Jonathan F. Finks, Dana A. Telem, Aaron J. Bonham, Amir A. Ghaferi, Oliver A. Varban, Nabeel R. Obeid |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Sleeve gastrectomy business.industry medicine.medical_treatment nutritional and metabolic diseases 030209 endocrinology & metabolism Health benefits medicine.disease Surgery 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus Hyperlipidemia medicine 030211 gastroenterology & hepatology In patient Healthy weight Metabolic disease business Body mass index |
| Zdroj: | Surgery for Obesity and Related Diseases. 16:248-253 |
| ISSN: | 1550-7289 |
| Popis: | Background Criteria for undergoing sleeve gastrectomy (SG) is restricted among patients with a body mass index (BMI) Objectives To determine if low-BMI patients experience similar health benefits after SG compared with patients with a BMI ≥35 kg/m2. Setting Teaching and nonteaching hospitals in Michigan. Methods Patients with a BMI Results Low-BMI patients were more likely to be older (50.7 versus 45.4 yr, P Conclusions Despite being older and with higher rates of metabolic disease, low-BMI patients reported high-resolution rates for diabetes, hypertension, and hyperlipidemia (>50%) and were more likely to achieve a healthy weight after SG. Abolishing the BMI threshold for SG among patients with metabolic disease should be considered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|